Yield10 Bioscience, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Kristi Snell, VP of Research and CSO at Yield10 Bioscience, reports a transaction involving common stock related to tax withholding upon RSU vesting.
OTC.Pink
Lynne H. Brum, VP of Planning and Communications at Yield10 Bioscience, reports the withholding of shares for tax obligations and acquisition of shares through the company's 401(k) plan.
OTC.Pink
Charles B. Haaser, VP Finance and CAO of Yield10 Bioscience, reports the withholding of shares for tax obligations and acquisition of shares through the company's 401(k) plan.
OTC.Pink
Oliver P. Peoples, CEO of Yield10 Bioscience, reports changes in beneficial ownership of company stock due to tax withholding and 401(k) contributions.
OTC.Pink
Director Jack W. Schuler reported the sale of 36,000 shares of Yield10 Bioscience, Inc. common stock at $0.20 per share on December 20, 2023.
OTC.Pink
Director Robert L. Van Nostrand acquired 11,924 shares of Yield10 Bioscience in lieu of cash compensation for board service during Q1 2024.
OTC.Pink
Anthony J Sinskey, a director at Yield10 Bioscience, acquired 20,561 shares of common stock in lieu of cash compensation for services rendered.
OTC.Pink
Director Richard William Hamilton acquired 41,118 shares of Yield10 Bioscience in lieu of $15,625 in cash compensation for board service.